Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.160 | 10 | 6054704 | intron variant | A/G | snv | 7.5E-02 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.160 | 10 | 6054704 | intron variant | A/G | snv | 7.5E-02 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 10 | 6053873 | intron variant | A/G | snv | 4.3E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 10 | 6053873 | intron variant | A/G | snv | 4.3E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 10 | 6053873 | intron variant | A/G | snv | 4.3E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 10 | 6051176 | intron variant | C/T | snv | 7.8E-03 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 10 | 6051176 | intron variant | C/T | snv | 7.8E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.080 | 10 | 6051176 | intron variant | C/T | snv | 7.8E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.080 | 10 | 6051176 | intron variant | C/T | snv | 7.8E-03 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 10 | 6039267 | intron variant | C/A | snv | 0.13 |
|
Digestive System Diseases | 0.800 | 1.000 | 2 | 2012 | 2015 | |||||||
|
1.000 | 0.040 | 10 | 6039267 | intron variant | C/A | snv | 0.13 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
10 | 6030130 | intron variant | G/C | snv | 7.8E-03 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.080 | 10 | 6027930 | intron variant | C/A;T | snv |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
10 | 6011200 | 3 prime UTR variant | T/A | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 10 | 6011605 | 3 prime UTR variant | C/T | snv | 0.42 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
10 | 6059897 | intron variant | T/A | snv | 1.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Immune System Diseases; Nervous System Diseases | 0.900 | 1.000 | 14 | 2007 | 2019 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.060 | 0.833 | 6 | 2009 | 2019 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.830 | 1.000 | 5 | 2012 | 2015 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Immune System Diseases | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 0.500 | 2 | 2009 | 2015 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |